Table 2 Patient and treatment characteristics
From: Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
Characteristic | Data |
|---|---|
Sex (n) | Â |
 Male | 16 |
 Female | 7 |
Age (years) | Â |
 Median | 64.5 |
 Range | 40 to 77 |
Disease (n) | Â |
 Hepatocellular carcinoma | 19 |
 Cholangiocarcinoma | 2 |
 Pancreatic neuroendocrine | 1 |
 Adrenal metastatic GIST | 1 |
Tumor vascular thrombosis (n) | Â |
 Hepatic portal vein | 6 |
 Inferior vena cava | 1 |
Treatment extent (n) | Â |
 Liver | 22 |
  Whole-liver | 9 |
  Lobar | 11 |
  Segmental | 2 |
 Organ other than liver | 1 |
No. of arterial territories (n) | Â |
 1 | 11 |
 2 | 9 |
 3 | 2 |
 4 | 1 |
Lung shunt (%) | Â |
 Median | 5.8 |
 Range | 1.5 to 24.2 |
Total injected 90Y activity (GBq) | Â |
 Median | 2.2 |
 Range | 1.1 to 5.0 |
Interval from radioembolization to PET (h) | Â |
 Median | 21.3 |
 Range | 4.7 to 24.0 |